Societal CDMO Inc (NAS:SCTL)
$ 1.1 0.01 (0.92%) Market Cap: 121.61 Mil Enterprise Value: 155.86 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 32/100

Q4 2020 Recro Pharma Inc Earnings Call Transcript

Feb 26, 2021 / 01:00PM GMT
Release Date Price: $3.43 (-30.14%)
Operator

Good day, ladies and gentlemen, and welcome to the Recro Fourth Quarter and Year-End 2020 Financial Results Conference Call. (Operator Instructions)

As a reminder, this conference call may be recorded. I would now like to hand the conference over to Stephanie Diaz of Recro's Investor Relations Group. Please go ahead.

Stephanie Diaz

Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer. Today, we will be providing an overview of Recro's contract development and manufacturing business, including updates on corporate activities and financial results for the year ended December 31, 2020. After our prepared remarks, we will welcome your questions.

Before we begin, I'd like to caution that comments made during this conference call today, February 26, 2021, will contain certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, concerning the current beliefs of the company, which involves a number of assertions,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot